Lippo China Resources to Seek Shareholder Approval on Director Re-elections, 20% Issuance Mandate and Articles Update at 8 June 2026 AGM

Bulletin Express
04/29

Lippo China Resources Limited has circulated a proxy form ahead of its Annual General Meeting scheduled for 11:00 a.m. on 8 June 2026 at the Renaissance Harbour View Hotel in Hong Kong. Shareholders are invited to vote on a series of ordinary and special resolutions that will shape the company’s governance and capital-management flexibility for the coming year.

Key ordinary resolutions: • Financial statements: Adoption of the audited financial statements and the directors’ and independent auditor’s reports for the year ended 31 December 2025. • Board composition: Re-election of Mr Brian Riady and Dr Stephen Riady as directors, with subsequent authorisation for the board to determine directors’ remuneration. • Auditor: Re-appointment of Ernst & Young as external auditor, with authority for the board to set its remuneration. • Capital mandates:  – Issuance mandate allowing the board to allot and issue additional shares up to 20% of the company’s issued share capital.  – Buy-back mandate permitting share repurchases of up to 10% of issued shares.  – Extension mandate enabling the issuance limit to be increased by the number of shares actually bought back under the 10% authority.

Special resolution: • Articles of Association: Approval of amendments and the adoption of an updated set of Articles to align corporate governance provisions with prevailing regulatory requirements.

Administrative notes: • Shareholders wishing to vote by proxy must lodge completed forms at the company’s registered office at least 48 hours before the meeting. • If no proxy is named, the meeting chairman will act as proxy. • Joint holders’ voting rights default to the first-named shareholder on the register.

The forthcoming AGM resolutions collectively address statutory reporting, board continuity, auditor retention, capital-management headroom and constitutional modernization, providing shareholders with a comprehensive agenda for corporate oversight.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10